United States  Video

“America's speediest news portal”
One News Page
"Lung Cancer" News 
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Veran Medical receives CE Mark clearance for its next generation SPiN Thoracic Navigation System™ for lung cancer

Veran Medical has received CE Mark clearance for its next generation ENB SPiN Thoracic Navigation System™ for lung cancer. The approval clears the way for Veran to accelerate commercialization..
PRWeb

Merck Posts Another Advance In The Lucrative Lung Cancer Market


SeekingAlpha

Videos for "Lung Cancer"

News video: Skin Implant Creates Mole-Like Tattoo that Could Detect Cancer

Skin Implant Creates Mole-Like Tattoo that Could Detect Cancer 00:55

Researchers from the ETH Zurich University have developed a skin implant that detects cancer. Tony Spitz has the details.
Source: Veuer -

News video: Immunotherapy Shows Lung Cancer Promise

Immunotherapy Shows Lung Cancer Promise


Source: WMGT -

News video: 19-Year-Old Brings Baseball Game to Ailing Grandma's Backyard So She Can Watch

19-Year-Old Brings Baseball Game to Ailing Grandma's Backyard So She Can Watch 00:44

An Illinois college student was so eager to have his terminally ill grandmother see him play that he gathered his team in her backyard to allow his biggest fan to catch one last game. Zach Seavers'..
Source: Inside Edition -

News video: Possible breakthrough on lung cancer

Possible breakthrough on lung cancer 00:53

Possible breakthrough on lung cancer
Source: Euronews English -

News video: New studies show hope in fighting lung cancer

New studies show hope in fighting lung cancer 03:52

Doctors have a powerful new approach to fighting lung cancer, the leading cause of cancer deaths. Two studies released Monday show drugs that boosted patients' immune systems can dramatically improve..
Source: CBS News -

 

Immune therapy doubles lung cancer survival rate

New drugs that trigger a patient’s immune system to kill malignant cells can greatly improve the survival rate of people with the most common type of lung cancer, a new study found. The study,..
bizjournals

New studies show hope for turning immune system against lung cancer

The idea of turning the immune system against cancer got a big boost over the last few days, with a trio of studies showing the approach’s effectiveness against lung cancer.
USATODAY.com

Merck Immunotherapy Drug Shines In Lung Cancer Study

Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who only got chemotherapy.
NPR

Austin cancer-fighting company Genprex names new president

Genprex is developming a treatment for non-small cell lung cancer called Oncoprex. It promoted from within for its new executive.
bizjournals

What you need to know on Wall Street today

what you need to know on wall street today
*Welcome to Finance Insider, Business Insider's summary of the top stories of the past 24 hours. Sign up here to get the best of Business Insider delivered direct to your inbox.* Bank of America..
Business Insider

Immune Therapy Scores Big Win Against Lung Cancer in Study

For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for..
Newsmax Also reported by •NewsdaySeattlePI.comSeattle Times

Merck shares pop as its Keytruda drug results power ahead of Bristol-Myers, Roche

Merck & Co (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY) and Roche Holding AG (VTX: ROG) cancer drugs all beat expectations, but Merck beat them a little more handily. Merck presented promising results..
Proactive Investors

2 cancer drugmakers just presented key data about how new treatments work in lung cancer — and the markets picked a winner (MRK, BMY)

2 cancer drugmakers just presented key data about how new treatments work in lung cancer — and the markets picked a winner (mrk, bmy)
· *Two cancer drugmaker rivals presented data on Monday about how combinations of their drugs, which harness the body's immune system to treat cancer, worked in treating a common form of lung cancer..
Business Insider

Bristol-Myers' Opdivo/Yervoy combo beats chemo in first-line lung cancer; shares down 5% on Merck Keytruda data


SeekingAlpha

Lung Cancer Patients Live Longer With Immune Therapy

Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
NYTimes.com

Merck lung cancer trial boosts immunotherapy hopes

Company says test results show ‘unambiguous’ improvement in survival rates 
FT.com

Jules Wagman, local author and JBJ founding editor, dies at age 90

Jules L. Wagman, 90, founding editor of the Jacksonville Business Journal, died April 13. He had been fighting lung cancer for more than three years. Wagman came to the First Coast in 1985 to start the..
bizjournals

Vortex Biosciences to Present Compelling Liquid Biopsy Data in Collaboration with Stanford University School of Medicine and UCLA at AACR 2018

Data demonstrates the use of the VTX-1 Liquid Biopsy System in isolating and analyzing circulating tumor cells for clinical biomarkers MENLO PARK, Calif. (PRWEB) April 14, 2018 Vortex..
PRWeb

Bristol-Myers falls after Citi analyst says Pfizer not interested in buying the drugmaker

Bristol-Myers Squibb Co (NYSE:BMY) shares were down Thursday while Pfizer Inc. (NYSE:PFE) rose after an analyst for Citi Investment Research said a deal between the two drugmakers isn't likely to..
Proactive Investors

Cynvenio and MD Anderson in Final Clinical Validation of LungLB(TM) Liquid Biopsy Lung Cancer Detection Diagnostic

LungLB(TM) will be the first cell-based non-invasive, blood test to rule-out patients with indeterminate lung nodules from having cancer. Over 20,000 patients per year in the United States receive an..
PRWeb

You Might Like


 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+